PT-141 is the same molecule as bremelanotide, which is approved as Vyleesi (#40) exclusively for hypoactive sexual desire disorder in premenopausal women. Vyleesi is administered as a subcutaneous ...
View full compound profile →Vendors stocking
17
across 4 countries
Total listings
21
20 in stock
Price range
£19.95–£54.00
Median price per mg
£2.10
Most common size
10mg
15 listings
Forms available
nasal spray, pre-mixed pen, lyophilised, tablet
Stock health
95%
17 vendors · 20 listings
5mg
1 listing
Avg price: £48.00
Avg per mg: £9.60
10mg
15 listings
Avg price: £34.85
Avg per mg: £3.48
30tablets
1 listing
Avg price: £49.95
Avg per mg: £1.67
This compound is sold as a research chemical and is not approved for human use. Information on this page is compiled from publicly available vendor listings and is provided for informational purposes only. PeptideTrace does not sell peptides, does not facilitate transactions, and does not recommend any vendor. Always verify product quality independently.
Prices last updated: 15 May 2026
Data sourced from 17 vendor websites across 4 countries
